United Drug's 2006 turnover rises 10%

27 November 2006

United Drug, a provider of services to pharmaceutical retailers and manufacturers and Ireland's largest pharmaceutical wholesaler, says that, in full-year 2006, its turnover rose 10% on the like, year-ago period to 1.46 billion euros ($1.89 million), as headline profit before amortization, property profit and tax, jumped 14% to 55.2 million euros, or 20.22 cents per diluted share. During the period, United concluded its drug pricing and supply discussions with the Irish Health Service Executive and the Irish Pharmaceutical Healthcare Association. The firm says that their new four-year agreement, which came into effect in September 2006, will provide savings to the Irish government of approximately 300.0 million euros over the period to 2010.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight